Functional selectivity in adrenergic and angiotensin signaling systems. - Wikidata - awgldk - TriplyDB

Functional selectivity in adrenergic and angiotensin signaling systems.

Functional selectivity in adrenergic and angiotensin signaling systems.

http://www.wikidata.org/entity/Q34359586

about

Brain Gαi 2 -subunit proteins and the prevention of salt sensitive hypertension Nuclear GPCRs in cardiomyocytes: an insider's view of β-adrenergic receptor signaling Functional selectivity of central Gα-subunit proteins in mediating the cardiovascular and renal excretory responses evoked by central α(2) -adrenoceptor activation in vivo Divergent label-free cell phenotypic pharmacology of ligands at the overexpressed β₂-adrenergic receptors.Angiotensin II signaling in human preadipose cells: participation of ERK1,2-dependent modulation of Akt.G protein coupled receptor kinases as therapeutic targets in cardiovascular disease.International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury.Functional selectivity of adenosine A1 receptor ligands?Human Neuropeptide S Receptor Is Activated via a Gαq Protein-biased Signaling Cascade by a Human Neuropeptide S Analog Lacking the C-terminal 10 Residues.Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation.β-arrestin1-biased β1-adrenergic receptor signaling regulates microRNA processing Taking the heart failure battle inside the cell: small molecule targeting of Gβγ subunits Functional relevance of biased signaling at the angiotensin II type 1 receptor.Functional selectivity of adenosine receptor ligands Molecular imaging with SERS-active nanoparticles.G-protein coupled receptor resensitization-appreciating the balancing act of receptor function.Molecular targets of current and prospective heart failure therapies.Adrenergic signaling in heart failure: a balance of toxic and protective effects.Conducting the G-protein Coupled Receptor (GPCR) Signaling Symphony in Cardiovascular Diseases: New Therapeutic Approaches G protein stoichiometry dictates biased agonism through distinct receptor-G protein partitioning.Update on the urotensinergic system: new trends in receptor localization, activation, and drug design Biochemical and pharmacological characterization of nuclear urotensin-II binding sites in rat heart.Biased signaling of the proton-sensing receptor OGR1 by benzodiazepines.Measurement of Receptor Signaling Bias.β-arrestin-biased agonism of β-adrenergic receptor regulates Dicer-mediated microRNA maturation to promote cardioprotective signaling.An investigation into the origin of the biased agonism associated with the urotensin II receptor activation.HBK-17, a 5-HT Receptor Ligand With Anxiolytic-Like Activity, Preferentially Activates ß-Arrestin Signaling

P2860

Q26782874-4AFC4A9D-57E1-45A7-9BC9-EB7E508FCF81 Q27026973-AA7ACA3F-2513-4C0E-9E7C-63183E25872B Q28575961-42FD2E59-3B80-47C9-ACC2-E5DE1CE6B04C Q31148493-D2E9754E-21BD-40AA-BED4-878EBC8C3C06 Q35009118-A5DCA430-E2D0-4E9D-AC3A-EF8D8E7FEC2B Q35135090-E5B35EF4-6996-4308-A583-591EE7966C68 Q36241932-265F8A75-953A-46DD-AD0F-2D9EFB1AA20F Q36312524-57B21E17-5E4C-49A4-BD24-DC116E29CF7B Q36598545-56DA646A-D36F-4FE9-AC61-E9B74968824E Q36755042-6AE025D5-1821-4C68-B97A-4DDF499C9EE1 Q36781030-772892F6-5F7F-4795-A7AB-31336B525D2C Q37638729-8E1D8D0F-8B31-4183-B3F6-A842178DE2C2 Q37831634-6269BA4D-A20B-40DD-8CF4-16943B203C51 Q37863171-783636BE-D19A-458F-AF42-22942EB02090 Q37872220-F62B62BC-06BA-457D-B400-DD6A970E0F0F Q37935679-7746FA70-7272-483C-8496-7B64B6AFE7C4 Q38018652-5132F219-5A33-4B78-92C9-F4598A250631 Q38076688-3737E8ED-BA8F-4673-8AE1-ED22AD2C1F3C Q38195518-40A6C093-BE19-427D-935D-AA3BE9573891 Q41206403-C44C0B16-703F-4A8E-9C5C-8266AC6E9021 Q41367745-9F3FCD36-5880-4D2C-85F5-A9514C17DB00 Q41767436-97D0D689-0632-4F76-980F-D55FD450B942 Q42252347-3B847E28-B024-43A1-A5BF-B5C5A0C1127E Q47435365-17BEE3F2-60BC-4BB1-A4DD-107264DBE31E Q51499124-E8B5FA3E-0976-462F-BF8E-3EDCFDF76FDA Q52329069-A5C6BCFB-319E-401C-92D0-5709C9673DC4 Q53165879-BAEA4291-29BE-4568-BA2F-8FB002E4CFF7 Q58554121-CB8D9308-EB1C-4310-9863-3FAD71115FA1

P2860

Functional selectivity in adrenergic and angiotensin signaling systems.

http://www.wikidata.org/entity/Q34359586

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Functional selectivity in adrenergic and angiotensin signaling systems.

@ast

Functional selectivity in adrenergic and angiotensin signaling systems.

@en

Functional selectivity in adrenergic and angiotensin signaling systems.

@nl

type

label

Functional selectivity in adrenergic and angiotensin signaling systems.

@ast

Functional selectivity in adrenergic and angiotensin signaling systems.

@en

Functional selectivity in adrenergic and angiotensin signaling systems.

@nl

prefLabel

Functional selectivity in adrenergic and angiotensin signaling systems.

@ast

Functional selectivity in adrenergic and angiotensin signaling systems.

@en

Functional selectivity in adrenergic and angiotensin signaling systems.

@nl

P1433

Q34359586-01BF5321-2D61-4374-94C8-0B6410B6E020

P1476

Q34359586-E8DE5A69-2F82-48B4-B4D3-F7E8494A9203

P2093

Q34359586-3176087E-9809-4750-98D9-25DA415A357D

Q34359586-AD4D6C8D-809D-4932-B50D-4F08D32DFC8B

Q34359586-FDC6DDB7-A1B8-48CE-BAAD-4C87A5E65EC1

P2860

Q34359586-0174083D-2438-4305-865E-6F91C57BB0F6

Q34359586-07FF7DBB-0A69-4E7E-9FEF-2810A9F90E9D

Q34359586-08B10371-EA36-402C-8A55-A0F1CC1B7A31

Q34359586-09A3634C-0C66-4C34-A480-C8C9BD2359CC

Q34359586-11BFB44A-F34E-4C0F-863A-3190B285B109

Q34359586-13781317-12AF-4C17-9493-665A5ACFC764

Q34359586-188B08D8-7643-4570-99F9-C9BE880FD64A

Q34359586-1F7B80E4-F338-4CD6-97F7-BEDF0CA1EAD2

Q34359586-222D4179-5A7D-4266-965E-8D477C404C50

Q34359586-2B451832-4530-49E4-8DE3-8422D6D4C821

P304

Q34359586-1A9DEC36-1CF6-4794-82A6-A87A8E7FE276

P31

Q34359586-1B950CA8-594E-487B-A5B5-4FED29012700

Q34359586-B9A40055-525C-423E-A430-79761B7E6505

P356

Q34359586-94EF6CB3-9190-4B14-B2E7-78E8F87A5BF7

P433

Q34359586-3AD84546-F7AA-478D-828F-9DFF6CA56DFB

P478

Q34359586-09A8EAD6-4990-4A7B-9EBF-B8CE2D079778

P577

Q34359586-125651DE-3094-460C-968D-7485718CCAD3

Q34359586-5033DE17-C5D6-4CBC-BD81-9973E966BC29

P5875

Q34359586-94807D02-9FEC-4ACC-AA2A-A14945B79538

P698

Q34359586-1CFDA963-155D-4B42-BF72-2BE2A35191E8

P921

Q34359586-1E9BA333-1186-4716-A33E-6254404365F8

Q34359586-24D6C55E-8AC9-4CB4-B0D0-0D2E28932986

Q34359586-3561E573-D311-498F-B212-46ACF8C9CCB1

Q34359586-4285E050-42AA-47D3-9E43-F98953D4E093

Q34359586-AFB83A35-0AB4-47D6-9E88-C7F5C184543A

P932

Q34359586-F6802124-8046-412B-A6CA-03C26FA5F3E8

P356

P1433

Molecular Pharmacology

P1476

Functional selectivity in adrenergic and angiotensin signaling systems.

@en

P2093

Chetan B Patel

http://www.w3.org/2001/XMLSchema#string

Howard A Rockman

http://www.w3.org/2001/XMLSchema#string

Nabila Noor

http://www.w3.org/2001/XMLSchema#string

P2860

Functional Selectivity and Classical Concepts of Quantitative Pharmacology

The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor

Functional specialization of beta-arrestin interactions revealed by proteomic analysis

Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2

Transduction of receptor signals by beta-arrestins

G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization

Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor

{beta}-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation

Regulation of carbamoyl phosphate synthetase by MAP kinase

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

P304

983-992

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/MOL.110.067066

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46380982

http://www.w3.org/2001/XMLSchema#string

P698

20855464

http://www.w3.org/2001/XMLSchema#string

P921

cell surface receptor

membrane proteins

nerve tissue proteins

P932

2993470

http://www.w3.org/2001/XMLSchema#string